Abstract Using reverse transcriptase polymerase chain reaction (RT-PCR) we evaluated the occurrence of tumour-cell ribonucleic acid (RNA) in the blood during surgery in patients with Ewing tumours. The patients received irradiation and chemotherapy according to the protocol of the European Intergroup Cooperative Ewing Sarcoma Study (EICESS) 92. Blood samples were taken from 15 patients. Intra-operative dissemination was found during 2/8 resections but showed no relation to patient survival. At second-look biopsy, detection of tumour-cell RNA was associated with relapse and metastases in 3/4 patients. The results suggest that pre-operative treatment did not completely prevent dissemination of tumour cells during surgery of Ewing tumours.
Introduction
Without prior chemotherapy, manipulation of primary localised malignant tumours has been shown to induce shedding of tumour cells into the bloodstream during surgery [1, 4, 8, 9] . The reverse transcription polymerase chain reaction (RT-PCR) was used for detection of tumour cells during surgery of breast cancer [1] , colorectal cancer [4] , prostate cancer [8] , and Ewing's sarcoma in blood samples from peripheral veins [17] . Tumour cells from peripheral veins of patients with breast cancer were viable [12] . The implantation of circulating tumour cells was minimised by host defences [6] in humans. Nevertheless, dissemination of tumour cells during surgery might support the development of metastases.
In patients with localised Ewing's sarcoma, systemic relapses of the disease have occurred despite good response to chemotherapy and irradiation [7] with less than 10% vital tumour. It is still a matter of speculation whether these treatment failures can be attributed to the shedding of tumour cells during resection. Therefore, it is of interest whether pre-operative systemic and local treatment has any protective effect against the dissemination of tumour cells during surgery. Ewing tumours are well characterised by a rearrangement of genes [3] . The presence of tumour-specific chimeric transcripts resulting from the fusion of these gene was used for highsensitivity detection of tumour cells in blood and bone marrow by the method of RT-PCR [11, 18, 15, 16] .
The aim of the present study was to document tumourcell dissemination into the blood by detection of tumourcell ribonucleic acid (RNA) during open biopsy before treatment, during second-look biopsy, or tumour resection after chemotherapy and irradiation.
Patients and methods
Fifteen patients at an age of 1.7-29 years (Table 1) were treated according to the protocol of the European Intergroup Cooperative Ewing Sarcoma Study (EICESS) 92. Treatment included chemotherapy with etoposide, vincristine, actinomycin D, ifosfamide and adriaymcin; irradiation and, if feasible, tumour resection. The tumours were classified histologically as Ewing tumours. Twelve of 15 patients had localised disease, two had synchronic lung metastases and one was a local relapse. Seven patients were studied at the time of biopsy before systemic treatment, eight during resection of the tumour and four during second-look biopsy after chemotherapy and local irradiation ( Table 2 ). Second-look biopsy was performed to confirm necrosis after chemotherapy and irradiation of inoperable tumours. Histological tumour response to therapy ( Table 2 ) was graded according to the criteria published by Salzer-Kuntschik [13] and adapted for Ewing tumours by Jürgens [7] . No decisions relevant to the treatment of the respective patients were drawn from the results of this study.
Tumour fragments from the primary tumour site were immediately snap-frozen in liquid nitrogen for characterisation of the fusion transcript type of the individual tumour (Table 1) . At biopsies and second-look surgeries, blood samples were collected from the peripheral venous blood through a fixed intravenous canula after onset of anaesthesia before incision of the skin and during skin closure. At resections, the samples were taken before skin incision, during tumour preparation and during skin closure. Additional samples were collected 2 days following surgery. Further samples were collected directly from the lowest spot of the operation field after opening of the bone or resection of the tumour, respectively. After red blood cell lysis followed by centrifugation, total RNA was isolated using the acid-guanidinium-phenol/chloroform method [2] . The resulting desoxyribonucleic acids (cDNAs) were PCR amplified under previously published conditions using adequate primers [3, 18] . In order to minimise the risk of sample-tosample contamination, a one-tube-nested RT-PCR protocol was applied and additional positive and negative controls were used as previously described [10] . The sensitivity of this method allows the detection of one tumour cell in 110 6 nucleated peripheral blood cells [11, 18] .
Results
During biopsy (patients 1, 2, 3, 4, 11, 13 and14), all samples from the operation site contained tumour-cell RNA. In the peripheral blood, tumour-cell RNA was detected in 1/7 samples before biopsy (patient 13) and in another one after biopsy (patient 2). Before second-look biopsy, the venous blood of 2/4 samples contained tumour-cell RNA. In two further patients, the peripheral blood turned positive during surgery. At the operation site, tumour-cell RNA was found in 2/4 samples. In none of the eight samples was tumour-cell RNA found in the peripheral blood before resection. At the operation site, tumour-cell RNA was detected in 2/8 samples 30 and 60 min after skin incision, respectively. At the end of surgery, tumour-cell RNA was detectable also in the peripheral blood of these two patients.
Clearance of tumour-cell RNA from peripheral blood was investigated in four patients. One patient still had tumour-cell RNA in the peripheral blood after 42 h, although she had received chemotherapy during this time. At definitive surgery, the tumour had to be classified as a non-responder. The median follow-up period was 3.1 (range 0.5-6.4 years). Nine months after tumour resection, one patient with histologically poor response to therapy had a local relapse. Two patients had a local relapse and one patient a systemic relapse 7 (range 5.5 -53 months) after second-look biopsy. In two patients ( Table 2 , patients 7 and 8) who had received only chemotherapy and irradiation, no vital tumour cells could be detected by conventional histology at second-look biopsy. Nevertheless, these patients were the only ones with RNA-positive samples in peripheral blood.
Discussion
Several investigations deal with the prognostic factors of Ewing tumours [7, 10] . Intra-operative dissemination of tumour cells may have been a reason for relapse in about 10% of Ewing tumours, despite good prognostic features such as small volume, good response to therapy and wide resection margins [7] . RT-PCR is a very sensitive and specific tool for detection of Ewing tumour cells. The detection of tumour-cell RNA at the operation site and peripheral blood confirm recent studies that described dissemination of carcinoma cells to peripheral blood [1, 4, 9] . Furthermore, the present study describes intra-operative mobilisation of tumour cells as evidenced by detection of RNA after chemotherapy and irradiation for the first time.
In other studies, the viability of circulating breast cancer cells was proven by colony growth [12] . In our investigation, RNA was detected in peripheral blood up to 42 h after surgery in a patient with a non-responding tumour. From these results, it can be deduced that we detected not only RNA but whole cells as well, since cell fragments and RNA should be cleared from blood within a few hours.
Detection of tumour-cell RNA at the operation site and in circulating blood during intra-lesional second-look biopsy indicates poor tumour response to local or systemic therapy, even if no tumour is found in the specimen by conventional histology. This observation might lead to the implementation of PCR in the course of diagnostics. Circulating tumour cells were dependent on the tumour volume [14] . Nevertheless, only the presence of tumour cells in the bone marrow but not in blood was associated with an adverse prognosis [5, 14] . The performance of second-look biopsies possibly should be discussed under the aspect that highly resistant tumour cells could be distributed. Especially under the conditions of patients having finished the maximum chemotherapy, we do not have sufficient means for further therapy. It remains to be verified whether circulating tumour cells arise from micro-metastatic sites or the local relapse [14] .
In the present study, we detected Ewing tumour-cell RNA at the operation site during wide resection of tumours that showed an excellent response to therapy. Detection of tumour-cell RNA showed no relation to the histological response to therapy. Both patients with RNApositive samples during resection survived 4.3 and 6.3 years without any evidence of disease. It has to be supposed that either dissemination of these tumour cells into the circulation did not result in metastases [6] or postoperative chemotherapy prevented a relapse.
Despite good response to pre-operative treatment, tumour cells survive until surgery. The detection of tumour-cell RNA in peripheral blood before or during second-look biopsy might be useful to modify the time course and doses of post-operative chemotherapy in these un-resectable tumours.
